MAPT and Alzheimer disease: The accumulation of tau and amyloid-β in AD patients begins more than 20 years before the disease onset, and there is a long asymptomatic or pre-clinical period despite accumulation of pathological proteins (Jack et al., 2013; Masters et al., 2015).